Log in to save to my catalogue

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2883159

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma

About this item

Full title

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2010-05, Vol.102 (11), p.1592-1599

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background:
Signal transducer and activator of transcription 3 (STAT3) regulates the expression of genes that mediate cell survival, proliferation, and angiogenesis and is aberrantly activated in various types of malignancies, including renal cell carcinoma (RCC). We examined whether it could be a novel therapeutic target for RCC by using the ST...

Alternative Titles

Full title

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2883159

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2883159

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/sj.bjc.6605691

How to access this item